Subject
Infectious Diseases,Virology
Reference31 articles.
1. HIV drug resistance against strand transfer integrase inhibitors;Anstett;Retrovirology,2017
2. For the SPRING-1 team. Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study;Stellbrink;AIDS,2013
3. For the extended SPRING-2 study group. Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, doubleblind, non-inferiority trial;Raffi;Lancet Infect. Dis.,2013
4. Dolutegravir regimen statistically superior to efavirenz/tenofovir/emtricitabine: 96-week results from the SINGLE study (ING114467), Boston, MA, USA; March 3–6;Walmsley;21st Conference on Retroviruses and Opportunistic Infections,2014
5. Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study;Molina;Lancet HIV,2015
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献